Pyrazinamide/rifampin induced acute autoimmune hepatits and thyroiditis: an unusual reaction

Novak, David J; Gange, Christopher A; Clement, Stephen; Lewis, James H
September 2003
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS96
Academic Journal
An abstract of the article " Pyrazinamide/Rifampin Induced Acute Autoimmune Hepatits and Thyroiditis: An Unusual Reaction," by David J. Novak, Christopher A. Gange, Stephen Clement and James H. Lewis is presented.


Related Articles

  • Autoimmune hepatitis in India: profile of an uncommon disease. Choudhuri, Gourdas; Somani, Sanjay K; Baba, Chalamalasetty S; Alexander, George // BMC Gastroenterology;2005, Vol. 5, p27 

    Background: Autoimmune hepatitis (AIH) has been reported to show considerable geographical variation in frequency and clinical manifestations. It is considered a rare cause of liver disease in India. The present study was undertaken to determine the incidence, clinical, biochemical and...

  • Medullary Thymic Epithelial Cells and Central Tolerance in Autoimmune Hepatitis Development: Novel Perspective from a New Mouse Model. Alexandropoulos, Konstantina; Bonito, Anthony J.; Weinstein, Erica G.; Herbin, Olivier // International Journal of Molecular Sciences;2015, Vol. 16 Issue 1, p1980 

    Autoimmune hepatitis (AIH) is an immune-mediated disorder that affects the liver parenchyma. Diagnosis usually occurs at the later stages of the disease, complicating efforts towards understanding the causes of disease development. While animal models are useful for studying the etiology of...

  • Clinical spectrum and therapeutic approach to hepatocellular injury in patients with hyperthyroidism. de Campos Mazo, Daniel Ferraz; de Vasconcelos, Graciana Bandeira Salgado; Albergaria Pereira, Maria Adelaide; de Mello, Evandro Sobroza; Bacchella, Telesforo; Carrilho, Flair Jose; Cançado, Eduardo Luiz Rachid // Clinical & Experimental Gastroenterology;Feb2013, Vol. 6, p9 

    Liver dysfunction in patients with hyperthyroidism includes abnormalities associated with the effects of thyroid hormone excess, those secondary to drug-induced liver injury, and changes resulting from concomitant liver disease. Our goal was to describe clinical, biochemical, and...

  • Emerging Treatments for Autoimmune Hepatitis. A. J. Czaja // Current Drug Targets - Inflammation & Allergy;Dec2002, Vol. 1 Issue 4, p317 

    Prednisone alone or a lower dose of prednisone in combination with azathioprine induces remission and enhances survival in autoimmune hepatitis. Treatment failure, incomplete response, drug-induced side effects, and relapse after drug withdrawal are unsatisfactory outcomes that justify the...

  • Azathioprine for Long-Term Maintenance of Remission in Autoimmune Hepatitis. Johnson, Philip J.; McFarlane, Ian G.; Williams, Roger // New England Journal of Medicine;10/12/95, Vol. 333 Issue 15, p958 

    Background: In most patients with autoimmune hepatitis, remission can be maintained with prednisolone, usually in combination with azathioprine, but the majority of patients have a relapse when treatment is stopped and therefore require long-term therapy. Because prolonged corticosteroid therapy...

  • Autoimmune Hepatitis. Meyer zum Büschenfelde, Karl-Hermann; Lohse, Ansgar W. // New England Journal of Medicine;10/12/95, Vol. 333 Issue 15, p1004 

    Editorial. Comments on the study by Philip Johnson et al on the long-term efficacy of immunosuppression in patients with autoimmune hepatitis, which appeared in the October 12, 1995 issue of the `New England Journal of Medicine.'

  • Efalizumab.  // Reactions Weekly;4/17/2010, Issue 1297, p23 

    The article describes the case of a woman who developed autoimmune hepatitis during treatment with efalizumab for plaque psoriasis.

  • Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Baeres, M.; Herkel, J.; Czaja, A.J.; Wies, I.; Kanzler, S.; Cancado, E.L.R.; Porta, G.; Nishioka, M.; Simon, T.; Daehnrich, C.; Schlumberger, W.; Galle, P.R.; Lohse, A.W. // Gut;Aug2002, Vol. 51 Issue 2, p259 

    Background: Antibodies to soluble liver antigen/liver pancreas (SLA/LP) are specific markers of autoimmune hepatitis. Their target antigen has recently been cloned. Aims: To establish standardised immunoassays using the recombinant antigen, and to assess the frequency and significance of...

  • Hepatitis terminology in the '90s. M.O.R. // Cortlandt Forum;09/25/97, Vol. 10 Issue 9, p90 

    Answers a query on the distinction between the terms `chronic active hepatitis' and `chronic persistent hepatitis.' Occurrence of chronic persistent hepatitis in patients with active liver disease; Understanding pathophysiology of viral hepatitis.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics